Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin.

[1]  S. Goldstein,et al.  Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides. , 2020, Biomarkers in medicine.

[2]  C. Ross,et al.  Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer , 2020, JAMA network open.

[3]  Zhenjiang Bai,et al.  The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates , 2019, Pediatric Research.

[4]  E. Hessey,et al.  Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study , 2018, Pediatric Nephrology.

[5]  Zhenjiang Bai,et al.  Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children , 2018, BMC Pediatrics.

[6]  P. Devarajan,et al.  Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass , 2017, Pediatric Nephrology.

[7]  Rajit K. Basu,et al.  Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery , 2017, Pediatric Nephrology.

[8]  E. Cebeci,et al.  Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients , 2017, International Urology and Nephrology.

[9]  C. Ronco,et al.  Pro: Prevention of acute kidney injury: time for teamwork and new biomarkers. , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  C. Ross,et al.  Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study , 2017, Canadian journal of kidney health and disease.

[11]  M. Moxey-Mims,et al.  Chronic kidney disease: Low birth weight and the global burden of kidney disease , 2016, Nature Reviews Nephrology.

[12]  B. Tönshoff,et al.  Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury , 2015, PloS one.

[13]  A. Zarbock,et al.  Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury after Pediatric Cardiac Surgery , 2014, PloS one.

[14]  J. Kellum,et al.  Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Azra Bihorac,et al.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury , 2013, Critical Care.

[16]  S. Goldstein.  Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? , 2010, Kidney international.

[17]  A. Craft,et al.  Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. , 2009, European journal of cancer.

[18]  W. Chai,et al.  Acute renal failure during sepsis: potential role of cell cycle regulation. , 2009, The Journal of infection.

[19]  S. Waikar,et al.  Urinary biomarkers in the early diagnosis of acute kidney injury. , 2008, Kidney international.

[20]  J. Campisi,et al.  Two faces of p53: aging and tumor suppression , 2007, Nucleic acids research.

[21]  S. Goldstein,et al.  Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study , 2007, Critical care.

[22]  S. Bottomley,et al.  Late effects of childhood cancer therapy. , 2003, Journal of pediatric nursing.

[23]  V. Dharnidharka,et al.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[25]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.